dihydroergotamine has been researched along with metaproterenol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Felgenhauer, WR | 1 |
Dygai, AM; Minakova, MY; Provalova, NV; Skurikhin, EG; Suslov, NI | 1 |
1 review(s) available for dihydroergotamine and metaproterenol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for dihydroergotamine and metaproterenol
Article | Year |
---|---|
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[Cerebral orthostatic hypotension (author's transl)].
Topics: Adult; Aged; Cerebrovascular Disorders; Dihydroergotamine; Female; Humans; Hypotension, Orthostatic; Male; Metaproterenol; Methods; Middle Aged; Ophthalmodynamometry | 1976 |
Mechanisms of regulation of erythropoiesis during experimental neuroses.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Central Nervous System; Colony-Forming Units Assay; Conflict, Psychological; Dihydroergotamine; Dopamine Agonists; Erythroid Precursor Cells; Erythropoiesis; Ganglionic Blockers; Hematopoietic System; Metaproterenol; Mice; Mice, Inbred CBA; Neurotic Disorders; Propranolol; Quaternary Ammonium Compounds; Receptors, Adrenergic; Reserpine; Sleep Deprivation; Sleep, REM | 2005 |